Carmolex, Inc., USA, is Pleased to Announce it has Entered into an…

Carmolex's advanced solutions/platform is poised to deliver Sanofi in Germany with a diverse set of high-quality chemotypes, pre-clinical, low molecular weight hits against biologically relevant…

(PRWeb October 18, 2012)

Read the full story at http://www.prweb.com/releases/2012/10/prweb10016134.htm

Click here for reuse options!
Copyright 2012 Biotechblog

Comments are closed.

%d bloggers like this: